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tRNAs have been discovered in the late 1950-ies of the 
last century and have subsequently been characterized 
biochemically, genetically and structurally as amino-acid 
delivering molecules for protein biosynthesis. First reports 
of stable tRNA-derived cleavage products have been 
reported in the late 1970-ies (1), but at that time they were 
mostly regarded as functionless degradation products. The 
advent of high-throughput sequencing techniques in the 
last years allowed the discovery of an unforeseen variety 
of small non-protein-coding RNAs (ncRNAs), including 
tRNA-derived RNA fragments (typically referred to as 
tdRs or tRFs), in all domains of life. Post-transcriptional 
RNA cleavage encompasses all sorts of transcripts including 
mRNAs as well as ncRNAs thus amplifying the biological 
repertoire of cellular RNomes significantly. Most of these 
small ncRNAs are involved in different steps of gene 
regulation. The most studied and well understood small 
ncRNA regulators are the ~22 nt long miRNA and siRNA 
involved in postranscriptional gene silencing, a process 
termed RNA interference (RNAi). Mi/siRNAs are present 
in almost all eukaryal cells and they regulate mRNA stability 
and/or translatability by utilizing sequence complementarity 
to their mRNA targets. tRNA-derived RNAs (tdRs) have 
meanwhile also made it on the ever growing list of ribo-
regulators. tdRs, which include tRNA halves (size 30–35 nt) 
as well as shorter fragments (~14–26 nt), were first 
discovered in cells exposed to different stress conditions 
[in E. coli infected with T4 virus (2); in Tetrahymena under 
amino acid starvation (3), in human cells (4)], but further 
studies have shown that they are also constitutively 
expressed in several cells and tissues. 
The biological function(s) of tdRs remained largely 
elusive until 2009, when it was shown that tdRs originated 
by cleavage of tRNAs in the anticodon loop were able to 
repress translation during stress (5). In vast contrast to mi/
siRNAs, that more or less all follow the same biogenesis in 
all species and, more importantly, execute their biological 
function in a highly homologous manner, tdRs are 
functionally extremely heterogeneous. First, they are not 
restricted to one domain of life since they have been found 
in archaea, bacteria as well as in uni- and multicellular 
eukarya. Second, the biological roles of tdRs embrace 
regulation of transcription (6), translation (5,7-9), stress 
granule formation (10), apoptosis (11), cell proliferation 
(12,13), RNAi (14), vesicle-mediated intercellular 
communication (6), and intergenerational inheritance (15) 
(Figure 1). Therefore, the mere detection of a tRNA 
fragment in a deep-sequencing screen does not allow 
reasonable deductions to be made about its biogenesis or 
function. This on the other hand means that basically each 
and every tRNA-derived fragment needs to be individually 
investigated by dedicated mechanistic studies. 
The paper published recently in Cell by Schorn et al. 
is a good example of such a focused tdR study (16). The 
authors open yet another chapter about the regulatory 
repertoire of tdRs. In this publication, they describe a so 
far unprecedented function of tdRs, namely as safeguards 
of genome integrity in mammalian cells. Retroviruses and 
retrotransposons are mobile elements present in many 
genomes that depend on unique enzymes, namely reverse 
transcriptase and transposase for their propagation. Due 
to their ability to “jump” to different locations they pose a 
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threat for potential germline mutations and therefore need 
to be tightly regulated. To keep them under control cells 
have developed a variety of strategies. Typically transcription 
of transposable elements is regulated epigenetically by DNA 
methylation (performed by DNMT1) and histone H3K9 
trimethylation by SETDB-1. Under certain circumstances 
though, cells need to achieve pluripotency and therefore 
undergo epigenetic reprogramming. When this happens 
the epigenetic markers that control transposable element 
mobility are also removed. To nevertheless prevent genome 
damage transposable elements are kept under control by 
means of other pathways that involve two families of small 
ncRNAs: piwi-interacting RNAs (piRNAs) and endogenous 
small interfering RNAs (endo-siRNAs). piRNAs act 
mainly in the germline while endo-siRNAs inactivate 
transposons immediately after fertilization (17). Until now 
there was no information about the regulatory mechanisms 
that prevent transposable element mobility during early 
embryo development, before the epigenetic marks are re-
established. Schorn et al. discovered a novel mechanism 
how tdRs are able to repress the mobility of long terminal 
repeat (LTR)-retrotransposons in preimplantation stem 
cells in mouse (16). Screening for small RNAs putatively 
involved in the control of transposable elements they could 
identify 3'-tdRs of 18- and 22-nt length, all containing 
the universally conserved 3'-CCA end of mature tRNAs. 
Figure 1 The multifaceted regulatory potential of tRNA-derived fragments. Under certain growth conditions full length tRNAs (center) 
can be processed into smaller tRNA-derived RNA fragments (tdRs), such as 5'- and 3'-fragments (green and blue, respectively). Cleavage in 
the anti-codon loop yields 5'- and 3'-tRNA halves (red). Examples for validated or suspected tdR regulatory functions and/or mechanisms 
for each tdR class are given in the respective colored section. Representative references are given in brackets.
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These tdRs show clear complementarity to specific regions 
of retrotransposons. The 18 nt tdRs identified match with 
almost perfect complementarity to the 5' UTR of the 
LTR-retrotransposon’s genomic sequence exactly at the 
highly conserved primer binding site (PBS). The PBS is an 
essential region of the primary retrotransposon transcript 
required for annealing of cellular full-length tRNAs to 
prime reverse transcription for cDNA synthesis. The 
authors could convincingly demonstrate that the 18 nt long 
tdR inhibited retrotransposition of the two most active 
mouse transposons using a plasmid-based retrotransposition 
assay in cell culture. This inhibition of transposition was 
not due to changes in the transcription levels as there were 
no apparent changes in the levels of histone methylation at 
relevant loci. The authors could also discard the possibility 
of an RNAi-like function of the 18-mer tdR, since no effects 
on the RNA stability and on the translational efficiency 
of retrotransposon mRNAs were observed. On the other 
hand, deep-sequencing of RNaseH cleavage intermediates, 
canonical processing products of the retroviral transcript 
that depends on the successful production of tRNA-primed 
cDNA in the regular life cycle, showed an inhibitory effect 
of tdRs on reverse transcriptase activity. In their mechanistic 
model, the authors suggest that the 18-mer tdR interferes 
with reverse transcription by hybridizing to the PBS and 
directly competing with the regular full-length tRNA 
usually utilized as primer for reverse transcription (Figure 1). 
The paper by Schorn et al. is not the first report of tdRs 
being possibly involved in regulating the retroviral life cycle. 
As early as in 2009 Yeung et al. identified a hybrid formed 
by an 18-mer tdR and the PBS of HIV-1 (18). In 2014 
Ruggero and colleagues discovered a 3'-tdR originating 
from tRNAPro of again 18-nt length fully complementary 
to the PBS of human T-cell leukemia virus HTLV-1 (19). 
In striking contrast to the study of Schorn et al . , 
this 18-mer tdR was proposed to stimulate priming of 
revere transcription in an in vitro reverse transcription assay. 
This example most impressively highlights the functional 
versatility of tdR biology: in both cases an 18-mer tdR 
shows perfect complementarity to the PBS of a retroviral 
transcript, yet one inhibits (16) and the other stimulates (19) 
cDNA production. In the study published in Cell by Schorn 
et al., the second most abundant tdRs were 22-nt long (16). 
This class of tdR differs from the above described 18-mer 
fragment only by four additional nucleotides at the 5' end. 
The 22-mer tdR, in contrast, seem to behave miRNA-like 
and has been shown to participate in regulating transposable 
elements at the translational level in retrotransposons that 
still carry the PBS (16).
Several important questions still await experimental 
confirmation in the proposed mechanism. One of the most 
urging ones is how are the two different species of 3'-
tdRs, the 18-mer and the 22-mer, produced? Is it the same 
enzyme or are different biogenesis pathways involved? 
Similar to the plethora of tdRs functional diversity, also 
the biogenesis of the various tdRs observed throughout 
different model system seem to be extremely heterogeneous. 
While it is well established that angiogenin, a small 
ribonuclease of the RNAse A family, is responsible for the 
production of stress-induced tRNA halves in mammalian 
cells (5,9), other eukarya that lack angiogenin orthologs 
are still capable of producing tRNA halves upon adverse 
environmental conditions (e.g., in Trypanosoma: (20) and our 
unpublished data). Homologues of RNase T2 (e.g., Rny1) 
are responsible for the production of tRNA halves in yeast 
and possibly also in plants. Other enzymes that have been 
implicated in 5'- or 3'-tdR processing in pro- and eukaryal 
species involve dicer, and colicin D & E5, to name a few 
(21,22). Another pending question to be addressed concerns 
the role of modified nucleosides in tRNA molecules for 
tdR biogenesis. tRNAs are known to carry numerous post-
transcriptionally added nucleobase and ribose modifications 
that are predominately located in and around the tRNA 
anticodon and the D- and the T-loops. It has been shown 
in some cases that indeed the presence of a particular tRNA 
modification affects the production of tdRs (23). The 
22-mer tdR identified in Schorn et al. could potentially 
contain two modified nucleosides at the 5'-end remaining 
from the corresponding T-loop modifications of the 
mature tRNALys, which was however not experimentally 
demonstrated in this publication (16). The 18-mer tdR 
that differs from the former by lacking the four utmost 
5' nucleosides are expected to be completely unmodified. 
It is tempting to speculate that these differences in the 
RNA modification pattern are involved in establishing the 
markedly different regulatory functions of these tdRs: the 
22-mer tdR resembles miRNAs and inhibits translation 
while the 18-mer tdR interferes with reverse transcription 
in an RNAi-independent manner (16). Comprehensive 
experimental focus on the role of modified nucleosides 
for tdR function as well as for tdR biogenesis is currently 
largely lacking in the field. It is conceivable that the still 
poorly understood and largely enigmatic biological roles of 
tRNA modification need to be re-evaluated in the light of 
tdR biology.
The pivotal role modifications play in tdR biology can 
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be better exemplified by studies on human diseases. It has 
been shown that lack of tRNA methylation positively affects 
the production of tdRs, and this in turn correlates with the 
severity of certain neurological disorders (23,24). These data 
highlight a possible causal connection between the tRNA-
modification pattern, tdR biogenesis as well as abundance, 
and disease progression. The connection between tdRs 
and human disease is not limited to neurodevelopmental 
disorders. Many studies have identified tdRs as major players 
in different types of cancer, affecting cancer malignancy and 
progression (for a recent review see ref. 25). 
It is surprising that the “mother molecule” of tdRs, 
genuine tRNA that is, has basically one major cellular 
role in targeting and delivering amino acids to translating 
ribosomes, while processing products thereof are 
functionally so multifaceted. Introduction of a single 
cleavage at a particular phosphodiester bond of a tRNA 
molecule thus can give birth to smaller RNA entities with 
completely different and unpredictable biological roles. 
Reports on this growing family of tRNA-derived small 
non-coding RNAs are accumulating in recent years and 
according to the tRFdb (http://genome.bioch.virginia.edu/
trfdb/) it already comprises more than 2,500 members. 
In summary, tdR research has undergone dramatic 
changes over the past 40 years: originally considered 
meaningless degradation products of tRNA, tdRs have 
proven to be crucial players in orchestrating gene regulation 
in health and disease. As the list of newly identified tdR 
sequence entries expands rapidly, so will hopefully the 
number of dedicated functional analyses for this incredibly 
versatile family of ncRNA molecules. 
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